Multiple bacterial proteins and biomolecules

Multiple bacterial proteins and biomolecules is a broad category representing the various cellular components that antibiotics interact with to inhibit or kill bacteria. Key targets include the penicillin-binding proteins (PBPs) essential for cell wall cross-linking, which are the primary targets of beta-lactam antibiotics like penicillin (StatPearls: Antibiotics, 2023). The bacterial ribosome, specifically the 30S and 50S subunits, serves as a target for numerous drug classes including tetracyclines and macrolides, which disrupt protein synthesis (PubMed: PMC4888801). Nucleic acid synthesis is another critical area, with enzymes like DNA gyrase and RNA polymerase being targeted by fluoroquinolones and rifamycins, respectively (Nature Reviews Microbiology, 2017). Additionally, metabolic pathways such as the synthesis of folic acid are targeted by sulfonamides (Microbiology Spectrum, 2016). These targets are fundamental to bacterial viability and pathogenesis, making them the cornerstone of infectious disease treatment. However, the non-specific targeting of these molecules across different bacterial species can lead to the disruption of the host's healthy microbiome and the development of antimicrobial resistance. Effective therapy requires selecting drugs that hit these targets with high specificity to minimize damage to the host's beneficial microbiota.

Other names

Bacterial targetsMicrobial biomoleculesProkaryotic targetsAntibiotic targets

Inhibition of essential bacterial processes including cell wall synthesis, protein translation, and nucleic acid replication.